Literature DB >> 24596334

Concurrent urothelial carcinoma in the renal pelvis of an allograft kidney and native recipient bladder: evidence of donor origin.

Ei-ichiro Takaoka1, Jun Miyazaki, Tomokazu Kimura, Takahiro Kojima, Koji Kawai, Yoshihiko Murata, Naoe Itoguchi, Yuko Minami, Takako Nakamura, Katsuya Honda, Hiroyuki Nishiyama.   

Abstract

A 44-year-old woman was admitted to the hospital for asymptomatic gross hematuria. At the age of 28, she underwent transplantation of a kidney from her father for end-stage renal disease secondary to rapidly progressive glomerulonephritis. She resumed peritoneal dialysis when the allograft kidney stopped functioning at the age of 42. Dialysis was continued for the next 2 years, when the hematuria occurred and she was readmitted. Radiologic evaluation and transurethral resection of the bladder tumor revealed a tumor of the renal pelvis of the allograft kidney (cT3N0M0) and multiple bladder tumors (cT1N0M0). Total cystectomy and allograft nephroureterectomy were performed. Histopathological examinations revealed high grade urothelial carcinoma in the renal pelvis of the allograft kidney (pT3) and native bladder (pT1). Fluorescence in situ hybridization of both specimens demonstrated that the renal pelvic tumors and bladder cancer possessed XY karyotypes. These results indicated that the urothelial carcinoma developed de novo in the renal pelvis of the allograft kidney and was implanted into the recipient's native bladder.

Entities:  

Keywords:  allograft kidney; fluorescence in situ hybridization; implantation; urothelial carcinoma

Mesh:

Substances:

Year:  2014        PMID: 24596334     DOI: 10.1093/jjco/hyu015

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

1.  Urothelial carcinoma of the allograft kidney developed in a renal transplant patient.

Authors:  Mehmet İlker Gökçe; Akın Fırat Kocaay; Serkan Aktürk; Acar Tüzüner
Journal:  Turk J Urol       Date:  2016-09

2.  Successful treatment of metastatic urothelial carcinoma arising in a transplanted renal allograft with paclitaxel, cisplatin, and gemcitabine combination therapy: a case report.

Authors:  Yasuyuki Kojima; Yuko Takahi; Naotsugu Ichimaru; Masayoshi Okumi; Shiro Takahara; Norio Nonomura
Journal:  BMC Res Notes       Date:  2015-02-04

3.  Transitional cell carcinoma involving graft kidney in a kidney transplant recipient: a case report.

Authors:  Yu Ah Hong; Hyeon Seok Hwang; Hae Joung Sul; Suk Young Kim; Yoon Kyung Chang
Journal:  BMC Nephrol       Date:  2017-09-21       Impact factor: 2.388

4.  Complete response to pembrolizumab for metastatic urothelial carcinoma in the renal pelvis of allograft kidney.

Authors:  Jun Kamei; Hirotaka Yokoyama; Toshiro Niki; Ryosuke Suda; Toru Sugihara; Akira Fujisaki; Satoshi Ando; Daiki Iwami; Tetsuya Fujimura
Journal:  IJU Case Rep       Date:  2022-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.